London, November 26, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Entia and is pleased to announce the placement of Timothy Broke-Smith as Senior Vice President of Partnerships.Working at the frontiers of remote patient monitoring and predictive analytics, Entia has combined novel at-home blood testing technology and digital solutions to deliver personalized insights into cancer patients’ journeys through treatment.The company’s flagship innovation –…
Europa Biosite is pleased to announce the acquisition of AMSBIO, a premier supplier of life science products and services, with expertise in the areas of biospecimens, stem cell research, 3D cell culture, glycobiology, and molecular biology. Headquartered in Oxford, UK, and with offices in both the USA and the Netherlands, AMSBIO serves life science researchers across Europe and throughout North America.
AMSBIO is an important strategic addition to Europa Biosite, further expanding the group’s offering in three high growth areas: biospecimens, stem cell research and regenerative medicine, as…
A new industry briefing note developed by Pioneer Group in collaboration with the UK chemicals sector community highlights the urgent need for the sector to transition to a more sustainable, circular economy.
The paper, developed at a ‘Pioneer Presents’ workshop held at the Wilton Centre, Tees Valley, earlier this year, outlines the environmental challenges associated with the sector’s current reliance on fossil resources, the potential of sustainable carbon feedstocks, and the significant actions required to transform the UK chemicals industry.
Over 40 representatives from industry, academia…
London, November 21, 2024 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, recently partnered with Solu Therapeutics (Solu) and is pleased to announce the placement of Sergio Santillana, MD, MSc, MBA, as Chief Medical Officer (CMO).Solu Therapeutics is a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas.As CMO, Dr. Santillana will oversee strategic direction and execution in Solu’s clinical development programs, leading efforts and…
Significant CRO C-suite experience expected to drive growth and commercial expansion into global markets
Cambridge, UK, 25 November 2024: Metrion Biosciences (“Metrion”), the specialist preclinical contract research organisation (CRO) and a leader in ion channel screening, today announced the appointment of Lee Patterson as its new CEO, effective from 2nd December 2024. An experienced life sciences and CRO executive, Lee will guide the Company as it seeks to execute an ambitious growth strategy, enhancing its specialist services and expanding further in key global markets. He succeeds Dr…
Medicilon's preclinical pharmacology and toxicology research team is equipped with a professional send format conversion team and has established a send data conversion platform that is fully developed in terms of software, technology, specification and quality, to realize accurate data conversion and provide a good environment for electronic data submission. In recent years, Medicilon SEND team helped customers complete many send data conversion projects within very tight timeline and filed timely with FDA. If your FDA IND-filing projects require SEND Format Conversion urgently, please…
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae
PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects
Glasgow, UK, 20 November 2024: Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private…
Cambridge, UK – November 15, 2024 – Stilla Technologies, a global leader in digital PCR (dPCR) solutions, has announced a strategic partnership with Source BioScience, a leading UK-based genomics service provider. This collaboration will bring cutting-edge dPCR technology to the forefront of molecular genetics in the UK and Ireland, with Source BioScience becoming the first provider in the region to offer Stilla’s NIO system.
The partnership will leverage Source BioScience’s infrastructure and expertise in molecular genetics and advanced applications in Next-Generation Sequencing (NGS). The…
A fantastic result for the Cushman & Wakefield EMEA Research and Insight team, taking the top spots at The Ian Cullen Research Prize at the Society of Property Researchers Annual Dinner.
The prize is for presentation of new data, innovative analysis and new ways of thinking.
The shortlist for the Open prize whittled down to just two papers – both by Cushman & Wakefield – Kiran Patel’s Locating Science and Sally Bruer’s European City Logistics.
The final selection for best research paper was awarded to Kiran Patel for Locating Science.
Locating Science is a data-led methodology for…
· EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies · Validates clinical value of multi-omics content in organ-specific extracellular vesicles for liver cancer detection· Data presented at AASLD Liver Meeting, held 15-19 November 2024, San Diego, CA
Cambridge, UK, and Boston, MA, USA, 18 November 2024: Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to…